HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N(6)- (2- (4- chlorophenyl)bicyclo(2.2.2.)- octyl)(3)- adenosine
enhances diazepam binding to brain benzodiazepine receptors
Also Known As:
EMD 28422; EMD-28422; Adenosine, N-(3-(4-chlorophenyl)bicyclo(2.2.2)oct-2-yl)-
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
Purine Nucleosides: 360
Adenosine: 12431
N(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
Nucleosides: 6847
Purine Nucleosides: 360
Adenosine: 12431
N(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine: 1
Ribonucleosides: 49
Adenosine: 12431
N(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine: 1
Related Diseases
1.
Seizures (Absence Seizure)
05/01/1980 - "
This increase in (3H) diazepam binding is due to an increase in the number of benzodiazepine receptors (Bmax) rather than an altered affinity of the radioligand for receptor (Kd), EMD 28422 protects mice against pentylenetetrazole and caffeine-induced seizures and potentiates the anticonvulsant action of subeffective doses of diazepam in a dose-dependent fashion.
"
Related Drugs and Biologics
1.
GABA-A Receptors (GABA(A) Receptor)
2.
Pentylenetetrazole (Metrazol)
3.
Diazepam (Valium)
4.
Caffeine (No Doz)
5.
Anticonvulsants (Antiepileptic Drugs)